This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2004 Sep 14;171(6):565-6.

doi: 10.1503/cmaj.1020352.

National pharmacare: a dog's tale

PMID: 15367455
PMCID: PMC516187
DOI: 10.1503/cmaj.1020352

National pharmacare: a dog's tale

Aslam H Anis. CMAJ. 2004.

. 2004 Sep 14;171(6):565-6.

doi: 10.1503/cmaj.1020352.

Author

PMID: 15367455
PMCID: PMC516187
DOI: 10.1503/cmaj.1020352

No abstract available

PubMed Disclaimer

Figures

None — Figure. First ministers line up to face the feds. Photo by: CP Photo/Fred Chartrand

See this image and copyright information in PMC

Similar articles

Waiting lists not pharmacare main issue: feds.
Sibbald B. Sibbald B. CMAJ. 2004 Sep 14;171(6):559. doi: 10.1503/cmaj.1041402. CMAJ. 2004. PMID: 15367451 Free PMC article. No abstract available.
Health resource allocation. A made-in-Canada description.
Noseworthy T. Noseworthy T. J Leg Med. 2011 Jan;32(1):11-26. doi: 10.1080/01947648.2011.550823. J Leg Med. 2011. PMID: 21391053 No abstract available.
Do provincial drug benefit initiatives create an effective policy lab? The evidence from Canada.
Pomey MP, Morgan S, Church J, Forest PG, Lavis JN, McIntosh T, Smith N, Petrela J, Martin E, Dobson S. Pomey MP, et al. J Health Polit Policy Law. 2010 Oct;35(5):705-42. doi: 10.1215/03616878-2010-025. J Health Polit Policy Law. 2010. PMID: 21123668
Hard decisions about fundamental values.
Laupacis A. Laupacis A. Healthc Pap. 2004;4(3):60-6; discussion 68-72. doi: 10.12927/hcpap..16878. Healthc Pap. 2004. PMID: 15114071 Review.
Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
von der Schulenburg J, Vauth C, Mittendorf T, Greiner W. von der Schulenburg J, et al. Eur J Health Econ. 2007 Sep;8 Suppl 1:S5-31. doi: 10.1007/s10198-007-0063-4. Eur J Health Econ. 2007. PMID: 17582539 Review.

See all similar articles

Cited by

Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.
Maclure M. Maclure M. Milbank Q. 2005;83(1):131-47. doi: 10.1111/j.0887-378X.2005.00338.x. Milbank Q. 2005. PMID: 15787956 Free PMC article. Review. No abstract available.

References

1. Commission on the future of health care in Canada. Final report. Building on values: the future of health care in Canada. November 2002. Health Canada: Ottawa. Available: www.hc-sc.gc.ca/english/care/romanow/hcc0086.html (accessed 2004 Aug 24).
1. Anis AH, Guh DP, Marra CA, Rashidi AA, Woolcott J, Lacaille D, et al. The unintended effects of cost-sharing for drugs among patients with rheumatoid arthritis. Arthritis Rheum 2003;48(9)(Supp):549.
1. Anis AH, Guh D, Wang X. A dog's breakfast: prescription drug coverage varies widely across Canada. Med Care 2001;39:315-26. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources